Publication | Closed Access

Mangiferin alleviates lipopolysaccharide and D-galactosamine-induced acute liver injury by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation

InflammationAnti-inflammatoryNrf2 PathwayHepatologyMedicineLiver PhysiologyImmunologyCell DeathPathologyNlrp3 Inflammasome ActivationHepatology InflammationHepatotoxicityAcute Liver FailureLiver DiseasePharmacologyDrug-induced Liver InjuryOxidative Stress